← back to search

Rubén Fernández‐Santiago

University of Tübingen · DE
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research focused on RAC1 and LRRK2, with related work in Disease, Dopaminergic, Toxicity. Notable publications include 'Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies', 'Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset', and 'The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity'.
h-index
—
citations
2,751
works
5
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson’s disease
Neurobiology of Aging 2020cited by 27position: middledoi
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
The Lancet Neurology 2019cited by 2,513position: middledoi
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
npj Parkinson s Disease 2019cited by 161position: middledoi
The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity
Molecular Neurobiology 2018cited by 48position: middledoi
Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity
Molecular Neurobiology 2018cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2018–2018)Pankaj Kapahi · Buck Institute for Research on Aging2 papers (2018–2018)Hanna Kim · Jeonbuk National University2 papers (2018–2018)— · 2 papers (2018–2018)Guy A. Caldwell · University of Alabama2 papers (2018–2018)Mario Ezquerra · University of Illinois Urbana-Champaign2 papers (2018–2018)— · 2 papers (2018–2018)Carles Calatayud · VIB-KU Leuven Center for Brain & Disease Research2 papers (2018–2018)Antonio Miranda‐Vizuete · The University of Texas Health Science Center at Houston2 papers (2018–2018)Miquel Vila · Universitat de Barcelona2 papers (2018–2018)Sanjib Guha · University of Rochester Medical Center2 papers (2018–2018)— · 2 papers (2018–2018)Antonella Consiglio · Universitat de Barcelona2 papers (2018–2018)Irene Fernández‐Carasa · Universitat de Barcelona2 papers (2018–2018)